Patent · US Active

MAD nucleases

US11085030B2 · kind B2 · utility

1Cited by
17References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 12, 2021
Grant dateAug 10, 2021
Priority date—
Expiry dateMar 12, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2800/80
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present disclosure provides new RNA-guided nucleases for making rational, direct edits to nucleic acids in live cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.